Variant report

Variant	rs7359509
Chromosome Location	chr17:17741875-17741876
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	YY1	chr17:17741711-17742000	HCT-116	colon:	n/a	n/a
2	POLR2A	chr17:17738858-17742063	HCT-116	colon:	n/a	n/a
3	STAT3	chr17:17741732-17741965	MCF10A-Er-Src	breast:	n/a	chr17:17741831-17741842 chr17:17741862-17741874
4	POLR2A	chr17:17739121-17742080	K562	blood:	n/a	n/a
5	TBL1XR1	chr17:17739088-17741992	K562	blood:	n/a	n/a
6	POLR2A	chr17:17738191-17742163	K562	blood:	n/a	n/a
7	POLR2A	chr17:17739299-17741979	K562	blood:	n/a	n/a
8	REST	chr17:17741371-17741948	K562	blood:	n/a	chr17:17741788-17741801
9	ELF1	chr17:17741679-17741977	HepG2	liver:	n/a	n/a
10	POLR2A	chr17:17739303-17742028	HepG2	liver:	n/a	n/a
11	POLR2A	chr17:17739119-17742142	HepG2	liver:	n/a	n/a
12	TBL1XR1	chr17:17740187-17742017	K562	blood:	n/a	n/a
13	TAL1	chr17:17740466-17741990	K562	blood:	n/a	n/a
14	HEY1	chr17:17741804-17742131	HepG2	liver:	n/a	n/a
15	JUND	chr17:17740154-17742073	K562	blood:	n/a	n/a
16	EP300	chr17:17739324-17742075	K562	blood:	n/a	chr17:17740222-17740231 chr17:17741723-17741736 chr17:17740254-17740270 chr17:17740272-17740281 chr17:17740210-17740226 chr17:17739654-17739662
17	EP300	chr17:17741494-17742108	A549	lung:	n/a	chr17:17741723-17741736
18	MAX	chr17:17741379-17741957	NB4	blood:	n/a	chr17:17741860-17741870
19	NFIC	chr17:17741536-17741889	HepG2	liver:	n/a	n/a
20	MYC	chr17:17741775-17741959	H1-hESC	embryonic stem cell:	n/a	chr17:17741860-17741870
21	RCOR1	chr17:17739374-17742071	K562	blood:	n/a	n/a
22	MYC	chr17:17739324-17741942	K562	blood:	n/a	chr17:17741860-17741870 chr17:17740306-17740316 chr17:17740165-17740175
23	POLR2A	chr17:17740656-17741940	A549	lung:	n/a	n/a
24	POLR2A	chr17:17739067-17742189	H1-hESC	embryonic stem cell:	n/a	n/a
25	POLR2A	chr17:17738800-17742206	PANC-1	pancreas:	n/a	n/a
26	POLR2A	chr17:17738216-17742184	HCT-116	colon:	n/a	n/a
27	POLR2A	chr17:17739302-17742055	Hela-S3	cervix:	n/a	n/a
28	POLR2A	chr17:17740651-17742008	H1-hESC	embryonic stem cell:	n/a	n/a
29	RCOR1	chr17:17741290-17741977	K562	blood:	n/a	n/a
30	STAT3	chr17:17741724-17741977	Hela-S3	cervix:	n/a	chr17:17741831-17741842 chr17:17741862-17741874
31	TCF7L2	chr17:17741733-17741933	PANC-1	pancreas:	n/a	n/a
32	POLR2A	chr17:17741435-17742101	H1-hESC	embryonic stem cell:	n/a	n/a
33	FOS	chr17:17741849-17741969	MCF10A-Er-Src	breast:	n/a	n/a
34	USF2	chr17:17740588-17742077	Hela-S3	cervix:	n/a	n/a
35	MAX	chr17:17738846-17742197	HCT-116	colon:	n/a	chr17:17741860-17741870 chr17:17740306-17740316 chr17:17740165-17740175
36	YY1	chr17:17741781-17741906	K562	blood:	n/a	n/a
37	FOXP2	chr17:17741690-17742001	SK-N-MC	brain:	n/a	n/a
38	POLR2A	chr17:17739052-17742048	SK-N-MC	brain:	n/a	n/a
39	SIN3AK20	chr17:17741305-17742145	A549	lung:	n/a	n/a
40	REST	chr17:17741619-17742062	A549	lung:	n/a	chr17:17741788-17741801
41	SIN3AK20	chr17:17741788-17742176	A549	lung:	n/a	n/a
42	TCF12	chr17:17738868-17742230	A549	lung:	n/a	n/a
43	ZBTB7A	chr17:17741413-17741893	K562	blood:	n/a	n/a
44	HEY1	chr17:17739229-17742083	HepG2	liver:	n/a	chr17:17740195-17740210 chr17:17739668-17739683
45	ELF1	chr17:17741660-17741922	HepG2	liver:	n/a	n/a
46	POLR2A	chr17:17739183-17741879	U87	brain:	n/a	n/a
47	MAZ	chr17:17741485-17741909	HepG2	liver:	n/a	chr17:17741860-17741870
48	RCOR1	chr17:17741874-17742069	HepG2	liver:	n/a	n/a
49	POLR2A	chr17:17738962-17742130	H1-hESC	embryonic stem cell:	n/a	n/a
50	IRF1	chr17:17741278-17742026	K562	blood:	n/a	chr17:17741303-17741320

No.	Distal block	Cell Line	Cell type
1	chr17:17630393..17635386-chr17:17740565..17747416,7	MCF-7	breast:
2	chr15:65596815..65597571-chr17:17741384..17741941,2	Hela-S3	cervix:
3	chr17:17580850..17587926-chr17:17737733..17744809,17	MCF-7	breast:
4	chr17:17594054..17595929-chr17:17740676..17742731,2	K562	blood:
5	chr17:17582541..17589441-chr17:17738170..17742091,10	K562	blood:
6	chr17:17615835..17618255-chr17:17741726..17743796,2	K562	blood:
7	chr17:17700084..17702891-chr17:17740296..17741974,2	MCF-7	breast:
8	chr17:17740765..17742638-chr18:3245655..3247781,2	MCF-7	breast:
9	chr12:57038481..57041021-chr17:17741070..17743316,2	K562	blood:
10	chr17:17584674..17588119-chr17:17738170..17742427,6	K562	blood:
11	chr17:17583946..17588364-chr17:17740477..17744360,6	MCF-7	breast:
12	chr17:17685438..17688763-chr17:17737889..17741903,5	K562	blood:
13	chr17:17741798..17744569-chr17:17877349..17878945,2	K562	blood:
14	chr17:17741535..17743958-chr17:17764231..17767571,3	K562	blood:
15	chr17:17741084..17743223-chr17:17876153..17877806,2	MCF-7	breast:
16	chr17:17596357..17599284-chr17:17741696..17744327,3	MCF-7	breast:
17	chr17:17672192..17674299-chr17:17741443..17743483,2	K562	blood:
18	chr17:17622624..17624957-chr17:17740328..17743276,2	K562	blood:

Variant related genes	Relation type
SREBF1	TF binding region
ENSG00000207031	Chromatin interaction
ENSG00000223979	Chromatin interaction
ENSG00000108557	Chromatin interaction
ENSG00000237328	Chromatin interaction
ENSG00000110955	Chromatin interaction
ENSG00000101608	Chromatin interaction
ENSG00000200156	Chromatin interaction
ENSG00000171962	Chromatin interaction
ENSG00000175662	Chromatin interaction
ENSG00000272688	Chromatin interaction

Extended variants
information (count: 153 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:120)

rs_ID	r²[population]
rs10048206	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs1052299	0.95[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.91[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.95[TSI][hapmap];0.85[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11078399	0.84[AMR][1000 genomes];0.91[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs11078400	0.86[CEU][hapmap];0.91[GIH][hapmap];0.87[MEX][hapmap];0.80[TSI][hapmap];0.87[EUR][1000 genomes]
rs11078406	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs11078408	0.80[MEX][hapmap]
rs1108648	0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11650649	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap];0.82[AMR][1000 genomes]
rs11650890	0.85[AMR][1000 genomes]
rs11652144	0.87[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11652881	0.91[CEU][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.84[TSI][hapmap];0.82[AMR][1000 genomes]
rs11653007	0.82[YRI][hapmap]
rs11654081	0.89[CEU][hapmap];0.84[JPT][hapmap]
rs11656665	0.95[CEU][hapmap];1.00[JPT][hapmap];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs11657074	0.87[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs11657130	0.87[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs11657423	0.81[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.85[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.95[TSI][hapmap];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs11658309	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs11870660	0.80[MEX][hapmap]
rs12450799	0.90[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs12936037	0.89[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs12936927	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs12938501	0.86[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs12941039	0.93[ASW][hapmap];0.86[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.87[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.87[TSI][hapmap];0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs12941356	0.81[ASN][1000 genomes]
rs12943500	1.00[CHB][hapmap];0.83[CHD][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs12946746	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12952723	0.81[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs12953299	1.00[CHB][hapmap]
rs13306736	0.83[AMR][1000 genomes];0.90[ASN][1000 genomes]
rs16960744	0.95[CEU][hapmap];0.87[GIH][hapmap];0.88[MEX][hapmap];0.89[TSI][hapmap];0.87[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs1889014	0.86[AMR][1000 genomes];0.80[EUR][1000 genomes]
rs1889018	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2236513	0.95[CEU][hapmap];1.00[JPT][hapmap];0.84[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs2297508	0.91[CEU][hapmap]
rs2350976	0.86[CEU][hapmap];0.85[CHD][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.84[TSI][hapmap];0.82[AMR][1000 genomes]
rs2350977	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs2955378	0.80[MEX][hapmap]
rs2955383	0.80[MEX][hapmap]
rs2955384	0.80[MEX][hapmap]
rs2955385	0.80[MEX][hapmap]
rs3183702	0.95[CEU][hapmap];0.90[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.86[TSI][hapmap];0.84[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs35451946	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3744113	0.84[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs3744115	0.91[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.95[TSI][hapmap];0.85[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs3818717	0.82[CEU][hapmap];0.85[CHD][hapmap];1.00[JPT][hapmap]
rs4244602	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs4257260	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs4299203	0.80[MEX][hapmap]
rs4341796	0.93[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.83[TSI][hapmap]
rs4413022	0.82[CEU][hapmap]
rs4459604	0.84[MEX][hapmap]
rs4470201	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs4924821	0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4924822	0.91[CEU][hapmap];0.90[GIH][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.91[TSI][hapmap];0.80[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs4924823	0.86[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.86[EUR][1000 genomes]
rs4924832	0.80[MEX][hapmap]
rs4925114	0.91[CEU][hapmap]
rs4925115	0.95[CEU][hapmap];0.86[TSI][hapmap];0.83[EUR][1000 genomes]
rs4925116	0.81[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs4925119	0.95[CEU][hapmap];0.90[GIH][hapmap];0.92[MEX][hapmap];0.93[TSI][hapmap];0.85[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs4925120	0.95[CEU][hapmap];0.87[GIH][hapmap];0.88[MEX][hapmap];0.89[TSI][hapmap];0.85[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs4925123	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap];0.84[AMR][1000 genomes]
rs4925125	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs4925126	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs4925129	1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap]
rs4925130	0.81[ASW][hapmap];1.00[CHB][hapmap];0.82[JPT][hapmap];0.92[MEX][hapmap]
rs5002487	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap]
rs56248913	0.87[AMR][1000 genomes]
rs58638639	0.84[EUR][1000 genomes]
rs6502618	0.84[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs6502619	1.00[CHB][hapmap];0.82[JPT][hapmap];0.87[AMR][1000 genomes]
rs6502622	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs6502624	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs6502625	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs6502629	1.00[CHB][hapmap];0.83[CHD][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs6502632	0.80[MEX][hapmap]
rs7207395	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs7212167	0.80[MEX][hapmap]
rs7213225	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs7214002	0.82[CEU][hapmap]
rs7219320	0.80[MEX][hapmap]
rs7222480	0.81[ASW][hapmap];0.82[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.96[MEX][hapmap];0.80[TSI][hapmap]
rs7224815	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs7501812	0.91[CEU][hapmap];1.00[CHB][hapmap];0.91[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.91[TSI][hapmap];0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs7503334	0.93[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.83[TSI][hapmap];0.87[AMR][1000 genomes]
rs7503747	0.81[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs8065416	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs8065497	0.81[AMR][1000 genomes]
rs8065563	0.93[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.83[TSI][hapmap];0.87[AMR][1000 genomes]
rs8066560	1.00[CEU][hapmap];0.97[GIH][hapmap];0.84[TSI][hapmap];0.94[EUR][1000 genomes]
rs8066982	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs8070128	1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap]
rs8070748	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs8073001	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs8078105	0.88[MEX][hapmap]
rs8078138	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap]
rs8078583	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs8078756	0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs8079321	0.86[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap];0.86[EUR][1000 genomes]
rs8080061	0.86[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap];0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8080823	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap]
rs950966	0.81[ASW][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.82[JPT][hapmap];0.96[MEX][hapmap];0.81[TSI][hapmap];0.84[AMR][1000 genomes]
rs9891957	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9893690	0.91[EUR][1000 genomes]
rs9894257	0.89[EUR][1000 genomes]
rs9895335	0.84[EUR][1000 genomes]
rs9895750	0.89[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs9899634	1.00[CEU][hapmap];1.00[CHB][hapmap];0.85[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.93[TSI][hapmap];0.89[AMR][1000 genomes];0.96[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs9902941	1.00[CEU][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];0.96[MEX][hapmap];0.93[TSI][hapmap];0.86[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs9906673	0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9907246	0.86[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.87[GIH][hapmap];1.00[JPT][hapmap];0.96[MEX][hapmap];0.84[TSI][hapmap];0.87[AMR][1000 genomes];0.88[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs9907287	0.86[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap];0.86[EUR][1000 genomes]
rs9908017	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs9908299	0.87[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs9911281	0.85[EUR][1000 genomes]
rs9912895	0.87[GIH][hapmap];0.88[MEX][hapmap]
rs9913277	0.84[MEX][hapmap]
rs9915248	0.95[CEU][hapmap];1.00[CHB][hapmap];0.83[CHD][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.96[MEX][hapmap];0.95[TSI][hapmap];0.86[AMR][1000 genomes];0.96[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs9915776	0.83[AMR][1000 genomes];0.95[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:33 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv907748	chr17:17412032-17782404	Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	89 gene(s)	inside rSNPs	diseases
2	nsv1065270	chr17:17430116-17823086	Weak transcription Flanking Active TSS Genic enhancers Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	91 gene(s)	inside rSNPs	diseases
3	nsv543236	chr17:17430116-17823086	Bivalent Enhancer Strong transcription Weak transcription Flanking Active TSS Enhancers Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	91 gene(s)	inside rSNPs	diseases
4	nsv907752	chr17:17569012-17750907	Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
5	nsv531183	chr17:17571035-18205309	Genic enhancers Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	123 gene(s)	inside rSNPs	diseases
6	nsv907753	chr17:17573539-17747289	Genic enhancers Enhancers Strong transcription Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
7	nsv907754	chr17:17573539-17782404	Strong transcription Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	78 gene(s)	inside rSNPs	diseases
8	nsv1061126	chr17:17578826-17803194	Strong transcription Genic enhancers Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	80 gene(s)	inside rSNPs	diseases
9	nsv543238	chr17:17578826-17803194	Flanking Active TSS Strong transcription Weak transcription Enhancers Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	80 gene(s)	inside rSNPs	diseases
10	nsv833385	chr17:17594037-17765578	Enhancers Genic enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
11	nsv1058884	chr17:17594370-17803194	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
12	nsv543240	chr17:17594370-17803194	Genic enhancers Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
13	nsv1064176	chr17:17596222-17803194	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
14	nsv543242	chr17:17596222-17803194	Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Genic enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
15	nsv1062361	chr17:17598407-17746899	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	73 gene(s)	inside rSNPs	diseases
16	nsv543243	chr17:17598407-17746899	Genic enhancers Enhancers Bivalent Enhancer Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	73 gene(s)	inside rSNPs	diseases
17	nsv907756	chr17:17619859-17747289	Enhancers Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
18	nsv522668	chr17:17619859-17752809	Flanking Active TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
19	nsv907757	chr17:17619859-17752809	Flanking Bivalent TSS/Enh Active TSS Strong transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
20	nsv907758	chr17:17619859-17782404	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
21	nsv907759	chr17:17619859-17802478	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
22	nsv1059949	chr17:17632590-17803194	Enhancers Genic enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	nsv543244	chr17:17632590-17803194	Weak transcription Flanking Active TSS Active TSS Genic enhancers Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv907760	chr17:17649423-17782404	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
25	nsv907761	chr17:17649423-17802478	Weak transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
26	nsv916653	chr17:17651916-18454952	Enhancers Strong transcription Active TSS Genic enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	144 gene(s)	inside rSNPs	diseases
27	nsv907762	chr17:17668071-17802478	Weak transcription Genic enhancers Active TSS Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
28	nsv907763	chr17:17673824-17749822	Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	69 gene(s)	inside rSNPs	diseases
29	nsv907764	chr17:17673824-17754633	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS Genic enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	70 gene(s)	inside rSNPs	diseases
30	nsv907765	chr17:17682484-17802478	Active TSS Strong transcription Enhancers Genic enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
31	nsv907766	chr17:17682484-17957348	Enhancers Strong transcription Flanking Active TSS Genic enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
32	nsv533142	chr17:17691726-18236686	Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	116 gene(s)	inside rSNPs	diseases
33	nsv907768	chr17:17709136-17747289	Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	68 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs7359509	TOM1L2	cis	parietal	SCAN
rs7359509	TOM1L2	cis	cerebellum	SCAN
rs7359509	SREBF1	cis	Whole Blood	GTEx

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17738400-17742200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
2	chr17:17739000-17742000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr17:17740200-17742200	Enhancers	Fetal Heart	heart
4	chr17:17740200-17742200	Enhancers	Fetal Lung	lung
5	chr17:17740400-17742000	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
6	chr17:17740400-17742000	Flanking Active TSS	Adipose Nuclei	Adipose
7	chr17:17740400-17742000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
8	chr17:17740400-17742200	Enhancers	Placenta Amnion	Placenta Amnion
9	chr17:17740400-17742200	Enhancers	Spleen	Spleen
10	chr17:17740400-17742200	Flanking Active TSS	A549	lung
11	chr17:17740400-17742200	Flanking Active TSS	Hela-S3	cervix
12	chr17:17740400-17742800	Enhancers	GM12878-XiMat	blood
13	chr17:17740400-17743000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr17:17740400-17743000	Enhancers	NHDF-Ad	bronchial
15	chr17:17740400-17743200	Weak transcription	Aorta	Aorta
16	chr17:17740600-17742000	Enhancers	Small Intestine	intestine
17	chr17:17740600-17742200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
18	chr17:17740600-17742200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr17:17740600-17742200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
20	chr17:17740600-17742200	Enhancers	Left Ventricle	heart
21	chr17:17740600-17742200	Enhancers	Pancreas	Pancrea
22	chr17:17740600-17742200	Flanking Active TSS	K562	blood
23	chr17:17740600-17743000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr17:17740600-17743000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
25	chr17:17740600-17743000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
26	chr17:17740600-17743000	Enhancers	Brain Anterior Caudate	brain
27	chr17:17740600-17743000	Enhancers	Esophagus	oesophagus
28	chr17:17740600-17743000	Enhancers	Fetal Muscle Trunk	muscle
29	chr17:17740600-17743000	Enhancers	Sigmoid Colon	Sigmoid Colon
30	chr17:17740600-17743000	Enhancers	HUVEC	blood vessel
31	chr17:17740600-17743000	Enhancers	NHLF	lung
32	chr17:17740600-17743200	Enhancers	Lung	lung
33	chr17:17740600-17743200	Weak transcription	Ovary	ovary
34	chr17:17740600-17743400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr17:17740800-17742000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr17:17740800-17742000	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr17:17740800-17742000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
38	chr17:17740800-17742000	Enhancers	Brain Angular Gyrus	brain
39	chr17:17740800-17742200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr17:17740800-17742200	Enhancers	Primary T helper naive cells from peripheral blood	blood
41	chr17:17740800-17742200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
42	chr17:17740800-17742200	Enhancers	Fetal Brain Female	brain
43	chr17:17740800-17742200	Enhancers	Right Ventricle	heart
44	chr17:17740800-17742200	Enhancers	NH-A	brain
45	chr17:17740800-17742800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr17:17740800-17742800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr17:17740800-17742800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
48	chr17:17740800-17742800	Enhancers	Primary T killer memory cells from peripheral blood	blood
49	chr17:17740800-17742800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr17:17740800-17742800	Enhancers	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links